Improvement of fatigue, physical functioning, and well-being among patients with severe impairment at baseline receiving ibrutinib in combination with bendamustine and rituximab for relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma in the HE
Leukemia & Lymphoma | January 3, 2018 | Volume: 59 | Issue: 9 | Pages: 2075-2084
10.1080/10428194.2017.1416364
| PMID 29295653